Tissue-specific effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the activity of 5′-deiodinases I and II in rats

Toxicology Letters

Volumn 147, Issue 2, 2004, Pages 133-142

  Viluksela, Matti ^a   Raasmaja, Atso ^b   Lebofsky, Margitta ^c   Stahl, Bernhard U ^d   Rozman, Karl K ^c,e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d BAYER AG   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; 5 Deiodinase; Rat; TCDD; Thyroid hormones; Toxicity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; ETHOXYRESORUFIN DEETHYLASE; IODIDE PEROXIDASE; ISOENZYME; LIOTHYRONINE; THYROID HORMONE; THYROXINE; THYROXINE DEIODINASE;

ADIPOSE TISSUE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYMOLOGY; KIDNEY; LIVER; MALE; METABOLISM; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; THYROID GLAND; TIME; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 1642563956     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.10.025     Document Type: Article

References (32)

1. Bastomsky C.H. Enhanced thyroxine metabolism and high uptake goiter in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology. 101:1977;292-296.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Brouwer A., Morse D.C., Lans M.C., Schuur A.G., Murk A.J., Klasson-Wehler E., Bergman Å., Visser T.J. Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol. Ind. Health. 14:1998;59-84.
4. Chanoine J.-P., Braverman L.E., Farwell A.P., Safran M., Sharon A., Dubord S., Leonard J. The thyroid gland is a major source of circulating T3 in the rat. J. Clin. Invest. 91:1993;2709-2713.
5. Dutton D.R., Parkinson A. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P-450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 268:1989;605-616.
6. Eltom S.E., Babish J.G., Ferguson D.C. The interaction of L-triiodothyronine and 2,3,7,8-tetrachlorodibenzo-p-dioxin on Ah-receptor-mediated hepatic phase I and phase II enzymes and iodothyronine 5′-deiodinase in thyroidectomized rats. Toxicol. Lett. 61:1992;125-139.
7. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:1996;173-179.
8. Gorski J.R., Muzi G., Weber L.W.D., Pereira D.W., Arceo R.J., Iatropoulos M.J., Rozman K. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Pathol. 16:1988;313-320.
9. Gorski J.R., Rozman K. Dose-response and time-course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicology. 44:1987;297-307.
10. Gupta B.N., Vos J.G., Moore J.A., Zinkl J.G., Bullock B.C. Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ. Health Perspect. 5:1973;125-140.
11. Henry E.C., Gasiewicz T.A. Changes in thyroid hormones and thyroxine glucuronidation in hamsters compared with rats following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 89:1987;165-174.
12. Larsen P.R., Silva J.E., Kaplan M.M. Relationships betweeen circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2:1981;87-102.
13. Leonard J.L., Mellen S.A., Larsen P.R. Thyroxine 5′-deiodinase activity in brown adipose tissue. Endocrinology. 112:1983;1153-1155.
14. Lubet R.A., Nims R.W., Mayer R.T., Cameron J.W., Schechtman L.M. Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicoumarol. Mutat. Res. 142:1985;127-131.
15. McKinney J.D. Multifunctional receptor model for dioxin and related compound toxic action: possible thyroid hormone-responsive effector-linked site. Environ. Health Perspect. 82:1989;323-336.
16. McKinney J.D., Waller C.L. Polychlorinated biphenyls as hormonally active structural analogues. Environ. Health Perspect. 102:1994;290-297.
17. Mills I., Raasmaja A., Moolten N., Lemack G., Silva J.E., Larsen P.R. Effect of thyroid status on cathecolamine stimulation of thyroxine 5′-deiodinase in brown adipose tissue. Am. J. Physiol. 256(Endocinol. Metab. 19):1989;E74-E79.
18. Morse D.C., Groen D., Veerman M., van Amerongen C.J., Koeter H.B., Smits van Prooije A.E., Visser T.J., Koeman J.H., Brouwer A. Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol. Appl. Pharmacol. 122:1993;27-33.
19. Morse D.C., Wehler E.K., Wesseling W., Koeman J.H., Brouwer A. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254). Toxicol. Appl. Pharmacol. 136:1996;269-279.
20. Pazos-Moura C.C., Moura E.G., Dorris M.L., Rehnmark S., Melendez L., Silva J.E., Taurog A. Effect of iodine deficiency and cold exposure on thyroxine 5′-deiodinase activity in various rat tissues. Am. J. Physiol. 260(Endocrinol. Metab. 23):1991;E175-E182.
21. Pohjanvirta R., Kulju T., Morselt A.F.W., Tuominen R., Juvonen R., Rozman K., Männistö P., Collan Y., Sainio E.-L., Tuomisto J. Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain. Fundam. Appl. Toxicol. 12:1989;698-712.
22. Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms and animal models. Pharmacol. Rev. 46:1994;483-549.
23. Raasmaja A., Viluksela M., Rozman K.K. Decreased liver type I 5′-deiodinase and increased brown adipose tissue type II 5′-deiodinase activity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated Long-Evans rats. Toxicology. 114:1996;199-205.
24. Rozman K., Pereira D., Iatropoulos M.J. Histopathology of interscapular brown adipose tissue, thyroid, and pancreas in 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-treated rats. Toxicol. Appl. Pharmacol. 82:1986a;551-559.
25. Rozman K., Pereira D., Iatropoulos M.J. Effect of a sublethal dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on interscapular brown adipose tissue of rats. Toxicol. Pathol. 15:1987;425-430.
26. Rozman K., Strassle B., Iatropoulos M.J. Brown adipose tissue is a target tissue in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity. Arch. Toxicol. Suppl. 9:1986b;356-360.
27. Schuur A.G., Boekhorst F.M., Brouwer A., Visser T.J. Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats. Endocrinology. 138:1997;3727-3734.
28. Silva J.E., Larsen P.R. Interrelationships among thyroxine, growth hormone, and the symphathetic nervous system in the regulation of 5′-iodothyronine deiodinase in rat brown adipose tissue. J. Clin. Invest. 77:1986;1214-1223.
29. Stahl B.U., Kettrup A., Rozman K. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part I: Acute toxicity and toxic equivalency factors (TEFs). Arch. Toxicol. 66:1992;471-477.
30. Tuomisto J.T., Viluksela M., Pohjanvirta R., Tuomisto J. The Ah receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines. Toxicol. Appl. Pharmacol. 155:1999;71-81.
31. Viluksela M., Bager Y., Tuomisto J.T., Scheu G., Unkila M., Pohjanvirta R., Flodström S., Kosma V.-M., Mäki-Paakkanen J., Vartiainen T., Klimm C., Schramm K.-W., Wärngård L., Tuomisto J. Liver tumor-promoting activity of 2,3,7,8-tetrachlodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Res. 60:2000;6911-6920.
32. Viluksela M., Duong T.V., Stahl B.U., Li X., Tuomisto J., Rozman K.K. Toxicokinetics of 2,3,7,8-tetrachloridibenzo-p-dioxin (TCDD) in two substrains of male Long-Evans rats after intravenous injection. Fundam. Appl. Toxicol. 31:1996;184-191.